UPL Ltd. experienced a precipitous 17% decline in its share price on Monday, February 23, as the market reacted cautiously to its board's approval of a comprehensive composite scheme of arrangement to create two distinct listed entities. The restructuring aims to fundamentally reconfigure the company's corporate structure by separating its diverse operations into UPL 1 (diversified agriculture and specialty chemicals) and UPL 2 (global crop protection powerhouse), with management anticipating that UPL Global will rank as the world's second-largest listed pure-play crop protection company operating across over 140 countries with annual revenues exceeding $5 billion. Despite the strategic rationale, the immediate market reaction signals deep-seated investor unease regarding UPL's persistent debt levels and execution risks. The 1.77% decline on announcement day (February 20, 2026) and the sharp 10% drop on February 23, 2026 underscore the market's skepticism about the complex restructuring process.
The restructuring, while described as cash and tax-neutral, critically fails to offer immediate debt reduction; instead, it reallocates the existing debt burden between the two newly formed entities. UPL Global is slated to carry approximately ₹19,000 crore of debt, while the standalone UPL entity will manage roughly ₹3,200 crore. This reallocation is a primary driver of investor skepticism, as total debt remains a significant factor, with analyses pointing to figures around ₹30,000 crore and a net debt/EBITDA ratio of 4.5x in fiscal 2024. While some reports indicate a reduction in net debt to ₹23,536 Cr by March 2025, the interest coverage ratio remains a concern, fluctuating between a healthy 9.81 and a more troubling 2.1x. Management has set a medium-term target of reducing the net debt/EBITDA ratio to 1.2x-1.5x, but the 12-to-15-month timeline for regulatory approvals means any potential deleveraging benefits are a distant prospect. The company's net debt-to-EBITDA ratio increased to 5.3 times in fiscal 2024, a significant jump from below 2 times in fiscal 2023, raising concerns about the immediate impact of the demerger on capital structure.
Analyst sentiment reflects a divided outlook, with consensus price targets around ₹823.76. Nuvama Institutional Equities downgraded its rating on UPL to 'Hold' from 'Buy', citing unresolved debt issues and potential dilution, while raising its target price to ₹816. Conversely, Anand Rathi reiterated its 'Buy' rating with an unchanged target of ₹860, acknowledging the strategic soundness of the restructuring but noting its limited immediate balance sheet impact. Antique Stock Broking also maintained a 'Buy' rating with a target of ₹880, while Motilal Oswal Financial Services suggested the move could support subsidiary-level capital raises and accelerate deleveraging. The future performance will heavily depend on management's clarity in communicating execution milestones and demonstrating tangible benefits from the reorganisation. Anand Rathi's target price of ₹860 implies a valuation of 15 times estimated FY28 earnings, contrasting with a November 2025 report that suggested a ₹820 target based on 16x H1 FY28 EPS. The company's historical sales growth has been modest at 5.46% over the past five years, and its return on equity has been low, raising questions about the underlying operational strength supporting the ambitious restructuring.
The restructuring involves a complex three-step execution process involving merging the Indian crop protection arm into UPL Limited, followed by a vertical demerger into UPL Global, and finally, incorporating international crop protection holdings into the new entity. The initiative involves consolidating its global and domestic franchises through this demerger process, streamlining the corporate structure and improving business visibility. Shareholders are set to receive shares in the new entity, UPL Global, on a 1:1 basis for every UPL share held. The planned IPO of Advanta, the company's seeds business, further streamlines the corporate landscape and is seen as a potential near-term catalyst. The separation aims to provide clearer valuation metrics for each business segment and facilitate more targeted growth strategies. However, the immediate market response indicates that investors are weighing the complexity and potential execution risks of this demerger against the anticipated benefits. The 12-15 month timeline for regulatory approvals presents a prolonged period of uncertainty, with the creation of two separate entities potentially leading to dilution of existing shareholder value if not managed meticulously.
The global crop protection market presents a robust opportunity, projected to surpass $121 billion by 2032, with UPL aiming for a #2 global position in pure-play crop protection. However, UPL currently faces competitive challenges, as it is the fifth-largest agrochemical company globally and growth forecasts, such as UPL's projected 8.1% annual increase through 2027, lag behind the industry average of 13%. The broader crop protection market is projected for steady growth, with an expected CAGR of 6.5% to 7.7% through 2026 and beyond, driven by global food demand and increased pest pressure. However, the sector also contends with escalating input costs and tightening regulatory environments, factors that could temper future growth. The projected industry growth is substantial, with market size expected to reach over $100 billion by 2030. The company commanded a market capitalization of approximately $9.8 billion prior to the announcement, with current estimates around ₹63,460 Cr. The promoter group's commitment to an 18-month lock-in on shares in the new global entity offers some stability, but concerns around potential shareholder dilution persist amid the complex restructuring process.
